Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-206 Phase III Trial in Ulcerative Colitis Remission Maintenance
jRCT2080220177Phase 3
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mesalazine in autoimmune colitis, sponsored by Zeria Pharmaceutical Co., Ltd.
02
Drugs
mesalazine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2080220177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220177.